VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1436381
Sex: M
Age:
State:

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Body aches; Fever (102F); Chills; This is a spontaneous report received from a non-contactable consumer, the patient. A 54 -year-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 20Mar2021 at 09:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number. EN6198) via an unspecified route of administration in the left arm on 27Feb2021at 09:00 (at the age of 54-years old) as a single dose for COVID-19 immunisation. On 20Mar2021 at 20:00, body temperature was measured and found to be 102-degree Fahrenheit. On 20Mar2021 at 20:00, the patient experienced a fever of 102-degree Fahrenheit, chills and body ache. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome for the events fever, body ache and body aches were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1436382
Sex: F
Age:
State: CT

Vax Date: 03/18/2021
Onset Date: 03/21/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Flat rash on both arms, across stomach and inner thighs; This is a spontaneous report received from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route of administration on 18Mar2021 at 09:00 (at the age of 70 years) as a single dose for COVID-19 immunisation. Medical history included high cholesterol and hypothyroid for an unknown duration. It was reported that the patient had same reaction to shingles vaccines a few years ago. The patient past drug history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), trazedone (MANUFACTURER UNKNOWN), thyroxine (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) within 2 weeks of vaccination and unknown if ongoing. The patient had not received any other vaccines within four weeks prior to the vaccination. On 21Mar2021, the patient experienced flat rash on both arms, across stomach and inner thighs. The patient had not received any treatment for the adverse events. The clinical outcome of the event flat rash on both arms, across stomach and inner thighs was not recovered at the time of the report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Trazedone; Multivitamin; ATORVASTATIN; THYROXINE

Current Illness:

ID: 1436383
Sex: M
Age:
State: CO

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: sleepiness; Minor ache at shot site; This is a spontaneous report received from a contactable consumer, the patient. A 54-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in right arm on 19Mar2021 at 14:30 (at the age of 54-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 19Mar2021 at 19:00, the patient experienced minor ache at shot site and mild sleepiness. No treatment was received by the patient for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events vaccination site pain and sleepiness was resolved at the time of this report. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1436384
Sex: F
Age:
State: AL

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Diarrhea; Vomiting; Chills; Body aches; Sweating; This is a spontaneous report from a contactable consumer. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration, on 20Mar2021, at 13:30, (at the age of 53 years), on left arm, as a single dose for COVID-19 immunisation. Medical history included EVB and COVID-19.Allergies to medications, food, or other products included penicillin, sulphates, lactose and gluten. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, at 14:30, the patient experienced diarrhea, vomiting, chills, body aches, and sweating. The adverse events were resulted in doctor or other healthcare professional office. Therapeutic measures were taken as a result of adverse event with Zophran, (MANUFACTURER UNKNOWN); fish oil, (MANUFACTURER UNKNOWN); Xanax, (MANUFACTURER UNKNOWN); Tylenol, (MANUFACTURER UNKNOWN). The clinical outcome of diarrhea, vomiting, chills, body aches, and sweating was unknown. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1436385
Sex: M
Age:
State:

Vax Date: 03/02/2021
Onset Date: 03/01/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This is a spontaneous report received from a non-contactable consumer. A 73-years-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in the arm left on 02Mar2021 (at the age of 73-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9265) via an unspecified route of administration on 09Feb2021 (at the age of 73-year-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021 (after getting the second dose of vaccination), the patients left elbow was swollen and stiff. It was reported that events were still persisting as of 21Mar2021. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of the event swollen elbow and stiff were resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436386
Sex: F
Age:
State: IL

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Minor soreness of top of left arm; This is a spontaneous report received from a contactable consumer, the patient. An 87-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 17Mar2021 at 10:00 (at the age of 87-year-old), as a single dose for COVID-19 immunisation. Medical history included allergies(unspecified). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not tested positive for COVID-19 since having the vaccine. On an unspecified date in Mar2021, the patient experienced minor soreness in the top of the left arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the adverse event. The clinical outcome of the event pain in arm was resolved on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436387
Sex: U
Age:
State: CT

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Left arm is sore / tender (the arm receiving the shot); Left arm is sore / tender (the arm receiving the shot); This is a spontaneous report from a contactable consumer. A 52-year-old patient of unspecified gender received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route of administration in the left arm on 20Mar2021 at 11:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 20Mar2021 at 19:00, the patient experienced left arm sore / tender (the arm receiving the shot). Therapeutic measures were taken as a result of reported events and included ADVIL. The events had not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event left arm was sore / tender (the arm receiving the shot) was recovering at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1436388
Sex: F
Age:
State: ME

Vax Date: 03/11/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Reaction on arm; Itchy; Red; swollen arm; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 11:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to Sulfa, eggs and shellfish. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included VIIBRYD, quetiapine (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and spironolactone (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 20Mar2021 at 10:00, the patient had reaction on arm on the ninth day following the vaccine. The patient reported that it was itchy, red and swollen. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events reaction on arm, itchy, red and swollen was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; SPIRONOLACTONE; VIIBRYD; QUETIAPINE

Current Illness:

ID: 1436389
Sex: F
Age:
State: TX

Vax Date: 03/12/2021
Onset Date: 03/15/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Nausea; vomiting about 3-4 days after vaccination; Fatigue; This is a spontaneous report received from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 13:00 (at the age of 21-years-old) as a single dose, for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included Aller-Zyr (as reported), diphenhydramine (Benadryl), fluoxetine (MANUFACTURER UNKNOWN) for an unknown indication received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 15Mar2021 at 22:00, the patient had experienced nausea, vomiting about 3-4 days after vaccination and fatigue as well. The patient did not receive any treatment for the reported events. Adverse events resulted in in doctor or other healthcare professional office or clinic visit. The clinical outcome of the events nausea, vomiting about 3-4 days after vaccination and fatigue was resolved on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: BENADRYL; FLUOXETINE

Current Illness:

ID: 1436390
Sex: F
Age:
State: NY

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Swollen tongue; burning sensation of tongue; tingling on the entire tongue; small bumps on the side of tongue; slight headach; mild body weakness; Sore throat; mild muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 36-Year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER 8727) via an unspecified route of administration on 19Mar2021 at 14:30 on the left arm as a single dose for COVID-19 immunisation. No known medical history No concomitant medication was not provided. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, the patient experienced swollen, burning sensation and tingling on the entire tongue; small bumps on the side of tongue, progressively worst on the very back; mild, sore throat; very slight headache and mild body weakness. No treatment was received for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of of the events swollen, burning sensation and tingling on the entire tongue; small bumps on the side of tongue, progressively worst on the very back; mild, sore throat; very slight headache; mild body weakness with mild muscle aches was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436391
Sex: M
Age:
State: AL

Vax Date: 02/11/2021
Onset Date: 02/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Incredibly weak; unsteady on feet; 6cm mass on neck; rash on legs; now food all tastes metallic; This is a spontaneous report received from a contactable consumer, the patient. An 89-year-old male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown), via an unspecified route in the right arm on 11Feb2021 at 09:00 as a single dose (at the age of 89-years-old) for COVID-19 immunisation. Medical history included benign prostate hypertrophy. The patient had no known allergies. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient had been tested for COVID-19 after vaccination. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN) and prostate pill (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. On 19Feb2021 at 14:00, the patient experienced incredibly weak, was unsteady on feet, had a 6cm mass on neck, rash on legs and food tasted metallic. It was reported that the patient was perfectly healthy prior to vaccine and had a great appetite prior. The events resulted in emergency room visit twice and the patient was treated for these events. On an unknown date, the patient underwent lab tests as treatment for events which included blood work, EKG, chest X-ray, urinalysis, CT scan all with normal results. All the testing done in emergency room had been normal except for mass on neck, it was scheduled to have biopsy of neck on 23Mar2021. The doctors suggested that it was all from the vaccine. The clinical outcome of the events incredibly weak, was unsteady on feet, had a 6cm mass on neck, rash on legs and food tasted metallic was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: Hydrochlorathiazide

Current Illness:

ID: 1436392
Sex: F
Age:
State: IL

Vax Date: 03/10/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Fatigue; Chills; Headache; Muscle pain; joint pain; Temperature 99.2; This is a spontaneous report received from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route administration in the left arm on 10Mar2021 at 10:00 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes 2 (type 2 diabetics) and neuroendocrine tumors in liver. The patient was allergic to sulfa (sulphonamide allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication includes levothyroxine (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all drugs were started on an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 at 13:00, the patient experienced fatigue, chills, headache, muscle pain, joint pain and temperature was 99.2 (body temperature increased) (unspecified units). The patient did not receive any treatment for adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events fatigue, chills, headache, muscle, joint pain and temperature 99.2 were not resolved at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXINE; ATORVASTATIN; OMEPRAZOL

Current Illness:

ID: 1436393
Sex: M
Age:
State: NY

Vax Date: 03/12/2021
Onset Date: 03/18/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Left side of face tender and swelling; Left side of face tender and swelling; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in the left arm on 12Mar2021 at 08:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroid. The patient did not have any allergies to medications, food, or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Mar2021 at 08:00, the patients left side of face was tender and had swelling. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse event left side of face tender and swelling. The clinical outcomes of the events tenderness and swelling face were not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1436394
Sex: F
Age:
State: LA

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Severe neck pain; Severe back pain; Diarrhea; Tingling; Severe cramps in foot, hands wrists and neck; Stomach cramps; Body aches on entire left side of body; Very sore arm; Headache; Shortness of breath with ears turning red; Joint ache; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 1002851398/en6199) via an unspecified route of administration in the left arm on 08Mar2021 at 16:30 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included interstitial cystitis, shellfish allergy and allergy to molds, environmental glues, acrylics, paints, household cleaners bleach. Concomitant medications included finasteride (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 08Mar2021 at 16:30, the patient experienced headache. On 08Mar2021 at 17:00, the patient experienced stomach cramps all night, body aches on entire left side of body with very sore arm and joint aches. Patient also experienced shortness of breath with ears turning red later that night. It lasted in various stages until 12Mar2021 including trouble breathing and joint aches continued. On 17Mar2021, the patient experienced entire left side of body tingling with severe cramps in foot, hands wrists and neck. On 18Mar2021, the patient experienced diarrhea. On 21Mar2021, the patient experienced severe neck and back pains. The patient did not receive any treatment for the reported events. The clinical outcome of headache, stomach cramps, body aches, very sore arm, shortness of breath, joint aches, tingling, cramps in foot, hands wrists and neck, diarrhea, neck pain and back pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Finaseride

Current Illness:

ID: 1436395
Sex: M
Age:
State: WA

Vax Date: 03/17/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Body rash; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the right arm on 17Mar2021 at 13:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The medical history of the patient was not reported. Concomitant medications included temisartan 80mg (MANUFACTURER UNKNOWN), valacyclovir 1gm (MANUFACTURER UNKNOWN) & citalopram 10mg (MANUFACTURER UNKNOWN), for unknown indications from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9265), via an unspecified route of administration in the left arm on 08Feb2021 at 19:00hours as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 19Mar2021 at 06:00, the patient experienced body rash. The patient did not receive any treatment for the adverse event. The clinical outcome of the event body rash was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: valacyclovir; TEMISARTAN; CITALOPRAM

Current Illness:

ID: 1436396
Sex: F
Age:
State: MI

Vax Date: 02/16/2021
Onset Date: 02/25/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Hives that lasted for 4 days; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9261), via an unspecified route of administration in the left arm on 16Feb2021 at 09:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation followed by second dose of BNT162b2(PFIZER BIONTECH COVID-19 mRNA VACCINE (lot number: EM9810) via unspecified route of administration on 17Mar2021, as single dose for COVID-19 immunisation. Medical history included high blood pressure, swelling in my legs, allergies, mild asthma, currently having issues with low potassium and sodium. The patient had known allergies to shellfish, codeine, and carmine. The patient received unspecified medication in two weeks of vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Feb2021 at 15:00, the patient experienced I got hives that lasted for 4 days (evenings and overnights mostly) 1 week and 2 days after the first dose. Therapeutic measure was taken as result of event and included treatment with benedryl. Event didn't result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome for event hives was recovered (lasted for 4 days) on an unknown date at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436397
Sex: F
Age:
State: OR

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Fatigue; bad headache (migraine type); nausea; vomiting; mild soreness at injection site; This is a spontaneous report from a contactable health care professional, the patient. A 55-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: NDC number: NDC:59267-1000-01(as reported)), via an unspecified route of administration in the left arm on 19Mar2021 at 16:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines and seasonal allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not allergic to medication, food and other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications within two weeks of vaccination included Vitamin D and C. The patient experienced fatigue, bad headache (migraine type), nausea, vomiting and mild soreness at injection site on 20Mar2021 at 05:00. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The patient did not receive treatment for reported events. The clinical outcome of fatigue, bad headache (migraine type), nausea, vomiting and mild soreness at injection site was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: Vitamin C; Vitamin D

Current Illness:

ID: 1436398
Sex: M
Age:
State: NY

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: 3 bowel movements in 8 hours; Unfocused Mind; This is a spontaneous report received from a contactable consumer, the patient. A 57-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in right arm on 20Mar2021 at 09:15 (at the age of 57-years) as a single dose for COVID-19 immunisation. Medical history included obesity, renal insufficiency and fatty liver. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 09:45 (35 minutes after injection), the patient had unfocused mind (easily lost his train of thought) for the duration of 6 hours. On 21Mar2021 (day after injection), the patient was ok in the morning and then had 3 bowel movements in 8 hours. The patient did not experience diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for these events. The clinical outcome of the event unfocused mind was recovered on 21Mar2021 and outcome of the event 3 bowel movements in 8 hours was unknown at the time of this report. No follow-up attempts are needed. No further information was expected.

Other Meds:

Current Illness:

ID: 1436399
Sex: M
Age:
State: MA

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Severe/ Debilitating Backache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 17Mar2021 at 14:15 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. No relevant medical history was reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. Concomitant medications included levothyroxine 100 (MANUFACTURER UNKNOWN), simvastatin 20mg (MANUFACTURER UNKNOWN), allopurinol (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unspecified date in Mar2021 at 15:30, the patient experienced severe / debilitating backache. The patient received ibuprofen as a treatment for the adverse event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe / debilitating backache was resolving at the time of this report. Information about lot number cannot be obtained. No further information is expected.

Other Meds: SIMVASTATIN; LEVOTHYROXINE; ALLOPURINOL

Current Illness:

ID: 1436400
Sex: M
Age:
State: NY

Vax Date: 03/10/2021
Onset Date: 03/17/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: I have a rash on the back of my both of my calves.; This is a spontaneous report received from a contactable consumer, the patient. A 41-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) as a single dose via an unspecified route of administration in her right arm on 10Mar2021 at 17:30(at the age of 41-years-old), for COVID-19 immunisation. The patients medical history included diabetes, clotting disorder and history of pulmonary embolism. Concomitant medications included several unspecified medications within two weeks of vaccination. The patient was known allergic to Benadryl. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not tested positive for COVID-19 since having the vaccine. The patient had not diagnosed with COVID-19 prior to vaccination. On 17Mar2021at 00:00 hours, the patient reported as he had a rash on the back of his both of his calves. It appeared 7 days after he was vaccinated. It does not itch much but it does get warm, and he had no other environmental changes or new medications. The patient did not receive treatment for the reported events. The clinical outcome for the event rash was not recovered at the time of this report. Information about lot number cannot be obtained. No further information is expected

Other Meds:

Current Illness:

ID: 1436401
Sex: F
Age:
State: KS

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Headache; Neck ache; Aches in all joints; Chills; Unable to sleep; Light sensitivity; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 18:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medications included vitamins, hormones, allergy pills and nose spray. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in the left arm on 27Feb2021 (at the age of 65-years-old) as a single dose for COVID-19 immunisation and experienced headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 03:00, the patient experienced headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity. Therapeutic treatment taken for the reported events included tylenol and alieve. The clinical outcome of the events headache, neck ache, aches in all joints, chills, unable to sleep and light sensitivity was resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436402
Sex: M
Age:
State: GA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: acne breakout on my scalp and on my temples; potential shingles flare up; burning/tingling sensation on the left side of my face; burning/tingling sensation on the left side of my face; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration in the right arm on 01Mar2021 at 11:30 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. Medical history included allergies to phenergan drug and strawberries. Concomitant medications taken within two weeks included PROPECIA, losartan pot (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and vitamin C (MANUFACTURER UNKNOWN) all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Mar2021, a day after vaccination, the patient had a bad acne breakout on his scalp and temples. On an unknown date in Mar2021 (two-week mark), the patient experienced burning/tingling sensation on the left side of his face (near to left eye) which the patient interpreted as a potential shingles flare up. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a results of event acne and shingles flare up included treatment with doxycycline (on dermatologist visit) on 03Mar2021 and Valtrex for 7 days, respectively. The clinical outcome of events acne, potential shingles, burning sensation and tingling was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Probiotic; Vitamin D; PROPECIA; Losartan Pot; Vitamin C

Current Illness:

ID: 1436403
Sex: M
Age:
State: VA

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Dizziness most of the time specially at night; This is spontaneous report from a contactable other healthcare professional, the patient. A 43-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in the left arm, on 17Mar2021 at 07:00, (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab tests and procedures, which included COVID-19 test on 08Oct2020, and the result was negative; nasal swab test on 07Nov2020 and the result was negative. Since the vaccination in 2021, the patient was tested for COVID-19 and the result was negative. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 18Mar2021 at 00:00, the patient experienced dizziness, it was there most of the time especially at night. The patient did not receive any treatment for the event. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of dizziness most of the time specially at night was not resolved at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1436404
Sex: F
Age:
State: VA

Vax Date: 03/08/2021
Onset Date: 03/18/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Swelling at injection site.; Redness at injection site.; Itchy rash at injection site; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199) via an unspecified route of administration in right arm on 08March2021 at 09:45 (at the age of 68-year-old), as a single dose for COVID-19 immunisation. Medical history included mild chronic obstructive pulmonary disease, high cholesterol and blood pressure. The patient was allergic to several pain medications, antibiotics and bee stings. The patient received unspecified medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccine within four weeks prior to COVID-19 vaccine. On 18March2021 at 12:30, after 10 days of vaccination the patient experienced injection site swelling, injection site redness and itchy rash at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events vaccination site swelling, vaccination site erythema and itchy rash. The clinical outcome of vaccination site swelling, vaccination site erythema and itchy rash was recovering at the time of this report. No follow up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436405
Sex: F
Age:
State: CA

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Minor sensation loss; Cold feeling right side of face, including around R eye, R mouth corner, R back of throat and tongue; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: PAA156051) via an unspecified route of administration on right arm on 20Mar2021 (at the age of 66 years old) at 07:15, as a single dose for COVID-19 immunisation. Medical history included high BP, cholesterol, osteoporosis, and sensory stroke from an unspecified date in Mar2020 (the patient was fully recovered). The patient was allergic to dust mites, and drugs erythromycin and dicloxacillin. Concomitant medication included unspecified medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 08:00, the patient experienced minor sensation loss, and cold feeling on the right side of face, including around right eye, right mouth corner, right back of throat and tongue. The patient underwent COVID-19 virus test on an unspecified date and the result was negative. No therapeutic measures were given for the events of sensory loss and cold feeling. The clinical outcome of sensation loss and cold feeling was recovered 4-5 hours later on 20Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436406
Sex: F
Age:
State: SC

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Tiredness; vomiting; feeling unwell; This is a spontaneous report received from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route administration in left arm on 19Mar2021 at 10:00(at the age of 39- years-old) as a single dose for COVID-19 immunisation. Medical history included post-traumatic stress disorder, attention deficit hyperactive disorder, migraines, spinal issues, diabetic, arthritis, sleep apnea and asthma from unknown date. The patient was prescribed medication (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 19Mar2021 at 11:00, the patient experienced tiredness, feeling unwell and vomiting. The patient underwent a nasal swab test on 20Mar2021 which resulted negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of events tiredness, feeling unwell and vomiting was recovering. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1436407
Sex: F
Age:
State: FL

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Eyes swollen; Lips swollen; Red mottled rash over entire body; Hives on right wrist.; Teeth were chattering.; This is a spontaneous report from a contactable nurse, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: EP6955), via an unspecified route of administration in the left arm on 19Mar2021 at 16:30 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. The patient's medical history included osteoporosis, asthma, hypothyroid, hypertension, hyperlipidaemia and allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 19Mar2021 at 16:30, the patient experienced red mottled rash over entire body with hives on right wrist, eyes and lips were swollen and teeth were chattering. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was treated with oral BENADRYL 50 mg. The clinical outcome of events red rash, hives, lip swelling, eye swelling and teeth chattering was resolved on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436408
Sex: F
Age:
State: NC

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Fever on and off; Slight nausea; Very unusual fatigue; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 18Mar2021 at 17:15 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included was not reported. The patient reported that her blood group was B negative and was healthy. The patient was allergic to metal, as stated that her skin could not tolerate anything that has nickel in it. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 19Mar2021 at 15:00, the patient experienced fever on and off, very unusual fatigue, some slight nausea and diarrhea. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, fatigue, nausea and diarrhea was not recovered. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1436409
Sex: F
Age:
State: NC

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This is a spontaneous report from contactable consumer, the patient. A 43year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: unknown) via unspecified route of administration on 20Mar2021 at 12:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included acetaminophen; aspirin; caffeine (EXCEDRIN) for unspecified indication from unknown date. The patient previously received first dose of BNT162b2 via unspecified route of administration in the right arm on 27Feb2021 at 10:15 hours (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient previously received rizatriptan (MANUFACTURER UNKNOWN), tramadol (MANUFACTURER UNKNOWN), ketorolac (MANUFACTURER UNKNOWN), naproxen sodium (ALEVE) and naproxen sodium (MANUFACTURER UNKNOWN) for unspecified indication from unknown dates and experienced drug allergy . The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient experienced very bad back mid and lower back pain on 21Mar2021 at 16:00. The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of back mid and lower back pain was unknown at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: Excedrin

Current Illness:

ID: 1436410
Sex: F
Age:
State: GA

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Shingles on face near mouth, on the right side.; This is a spontaneous report received from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021, at 11:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar I disorder, type 2 diabetes mellitus, generalised anxiety disorder (GAD) and chronic bronchitis. The patient had history of allergy to penicillin. Concomitant medications included aripiprazole (ABILIFY), quetiapine (SEROQUEL), clonazepam (KLONOPIN) and lamotrigine (LAMICTAL), all for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Mar2021, at 09:00, the patient had shingles on her face near mouth in the right side. Therapeutic measures were taken as a result of shingles included valacyclovir (VALTREX). Adverse event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event shingles was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: KLONOPIN; LAMICTAL; ABILIFY; SEROQUEL

Current Illness:

ID: 1436411
Sex: F
Age:
State: TN

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Headache; fatigue; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the left arm on 17Mar2021 at 15:00 (at the age of 37-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 diagnosed prior to vaccination. Patient had no allergy to medications, food, or other products. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included ADDERALL and CLOMID for an unspecified indication on an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021 at 17:00, the patient experienced headache, fatigue and sore arm. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the headache, fatigue and sore arm was resolved on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds: Chlomid; Aderall

Current Illness:

ID: 1436412
Sex: F
Age:
State: ID

Vax Date: 03/17/2021
Onset Date: 03/18/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: This is a spontaneous report received from a consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration to left arm on 17Mar2021 at 18:15 (at the age of 56-year-old), as a single dose for COVID-19 immunisation. Medical history of the patient included diabetic. Concomitant medications were not reported. The patient had allergies to sulpha drug. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received EFFECTOR XR and XIGDUO medications within 2 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was tested for COVID-19. On 18Mar2021 (day after the vaccine), the patient experienced injection site sore in arm hurt (vaccination site pain). On 19Mar2021, the patient had sore throat and cough, sneezing, chills, head and body aches. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events vaccination site pain, sore throat, cough, sneezing, chills, headache and body aches was not resolved at the time of this report. No follow-up attempts are possible; information about lot number cannot be obtained.

Other Meds: XIGDUO; Effector XR

Current Illness:

ID: 1436413
Sex: F
Age:
State: UT

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Extreme fatigue; Sore muscles all over body; Mild headache; This is a spontaneous report received from a contactable consumer, the patient. A 49-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: Unknown) via an unspecified route of administration in the left arm on 11Mar2021 at 09:00, (at the age of 49 years old) as a single dose for COVID-19 immunisation. Medical history included Diabetes, hypo thyroiditis and overweight. Concomitant medication included metformin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURERUNKNOWN) for unknown indication from unknown date. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 20:00, patient experienced extreme fatigue, sore muscles all over body and mild headache. The patient did not receive treatment for the reported events. It was reported that adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the fatigue. muscle soreness and headache were recovering. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXINE; METFORMIN

Current Illness:

ID: 1436414
Sex: F
Age:
State: DC

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Severe pain at jab site; shoulder (joints), neck and upper back, all localized to left side; This is a spontaneous report from a non-contactable consumer, the patient. A 52-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: EN6206) via an unknown route of administration at left arm on 18Mar2021 at 13:30 (at the age of 52-years) as a single dose for COVID-19 immunisation. The patient had allergy to soy, gluten intolerance, environmental allergies. Concomitant medications included Ibuprofen (MANUFACTURER UNKNOWN) and acetaminophen (MANUFACTURER UNKNOWN) within last two weeks for unknown indications. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested positive for COVID-19 since having the vaccine. Post vaccination, at 21:00, the patient experienced "severe pain at jab site, shoulder (joints), neck and upper back, all localized to left side". The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The treatment received included ice packs under and over arm, on upper back, neck (as reported) for the events vaccination site pain and pain in joint. The clinical outcome of the events vaccination site pain and pain in joint was resolved with sequelae (recovered with lasting effects as reported) on 21Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds: IBUPROFEN; ACETAMINOPHEN

Current Illness:

ID: 1436415
Sex: M
Age:
State: NC

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Body aches; Fever; Diarrhea; Joint pain; Headache; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old adult male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: ER8727), via an unspecified route of administration in the left arm on 20Mar2021, at 10:30 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, high blood pressure and high cholesterol. The patient had no allergies to food or medications. Concomitant medications included diltiazem (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and fluvoxamine (MANUFACTURER UNKNOWN), all from an unknown date and for unknown indication. Prior to vaccination, the patient had no symptoms associated for COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 19Mar2021 at 13:00, the patient experienced fever, body aches, diarrhea, joint pain, headache and sore arm. No therapeutic measures were taken as a result of events. The clinical outcome of events fever, body aches, diarrhea, joint pain, headache and sore arm were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: ATORVASTATIN; DILTIAZEM; FLUVOXAMINE; LISINOPRIL

Current Illness:

ID: 1436416
Sex: F
Age:
State: IA

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Mild diarrhea; nausea; This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route administration in left arm on 19Mar2021 at 16:15 (at the age of 51-years-old) as a single dose, for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within two weeks prior to the vaccination. On 20Mar2021 at 17:00, 24 hours after vaccine was administered, the patient experienced mild diarrhea and nausea for 6 hours. The patient did not receive any treatment for the events mild diarrhoea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events nausea and diarrhoea was recovered on an unknown date. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1436417
Sex: M
Age:
State: MN

Vax Date:
Onset Date: 03/15/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Extreme muscle pain over entire body; Headache; Skin pain; Chills; Sweat; Hard to keep my balance; This is a spontaneous report from a contactable consumer, patient. A 79-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on unknown date (at the age of 79-year-old) as a single dose for COVID-19 immunization. Medical history included blood pressure high. The patient had known allergy with sulfa drugs. The patient taken other medications (unspecified) within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced extreme muscle pain over entire body, headache, skin pain, chills, sweat, hard to keep his balance on 15Mar2021 at 23:00. Therapeutic measures included treatment with high doses of Tylenol. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme muscle pain over entire body, headache, skin pain, chills, sweat, hard to keep his balance was recovered on an unknown date. Information about lot/ batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1436418
Sex: F
Age:
State: IL

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Swollen lips; Swollen neck; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via an unspecified route of administration in the right arm on 20Mar2021 at 14:00 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included type 1 diabetes. The patient did not have any allergies to medications, food, or other products. Concomitant medications included NORVASC, LANTUS, lisinopril (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 21Mar2021 at 08:00, the patient experienced swollen neck and lips. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the swollen neck and lips was not recovered at the time of this report. Information about lot number cannot be obtained. No further information expected.

Other Meds: LANTUS; LISINOPRIL; NORVASC; ATORVASTATIN

Current Illness:

ID: 1436419
Sex: F
Age:
State: NY

Vax Date: 03/11/2021
Onset Date: 03/17/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: mouth dryness; lymph nodes swollen; rash on face, arms, torso, backand thighs; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL3247) via an unspecified route of administration in left arm on 11Mar2021 at 11:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication includes unspecified vitamins (MANUFACTURER UNKNOWN) and biotin (MANUFACTURER UNKNOWN) taken for unspecified indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Since the vaccination, the patient had not been tested positive for COVID-19. On 17Mar2021, the patient experienced mouth dryness, lymph nodes swollen and rash on face, arms, torso, back and thighs. At the time of this report (since 5 days), the events were still persisting. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with ZYRTEC for rash and dry mouth. The clinical outcome of the events mouth dryness, lymph nodes swollen and rash on face, arms, torso, back and thighs were not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: BIOTIN

Current Illness:

ID: 1436420
Sex: M
Age:
State: AR

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Severe soreness in left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 19Mar2021 at 10:45 (at the age of 52-years old) as a single dose for COVID-19 immunisation. Medical history included soreness. The patient was not allergic to any food, medications, or other products. The patient received unspecified medications within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Past drug history included unspecified injection for which patient experienced soreness. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 19Mar2021 at 10:45, the patient experienced severe soreness in left arm to the point where it was hurting to use it and was painful. The patient stated that, it was not like the other unspecified injection soreness which she had experienced in the past. The patient did not receive treatment for the adverse event. The clinical outcome for the event severe soreness in left arm was resolving. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1436421
Sex: M
Age:
State: NY

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Headache; Fatigue; Dizziness; This is a spontaneous report received from a contactable consumer, the parent. A 19-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EP6955), via an unspecified route of administration in the left arm on 20Mar2021 at 11:30 (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history included autism spectrum disorder (Asperger's Syndrome). The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 21Mar2021 at 00:00, the patient experienced fatigue, dizziness and headache. The patient did not receive any treatment for the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, dizziness and headache were recovered on 21Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436422
Sex: M
Age:
State: CO

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Stabbing pain in joints especially leftand right shoulders and right knee, butalso big toes and thumbs; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration on 18Mar2021 at 10:00 (at the age of 67-years-old), as a single dose for COVID-19 immunisation. The patient previously, received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via an unspecified route of administration to the left arm on 25Feb2021 at 1000, as a single dose for COVID-19 immunisation. Medical history included severe osteoarthritis. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks of the COVID-19 vaccine. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), vicodin (MANUFACTURER UNKNOWN), celebrex (MANUFACTURER UNKNOWN) and cyclobenzaprine (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 22:00, the patient experienced stabbing pain in joints involving the left and right shoulders, right knee, big toes and thumbs. The patient did not receive any treatment for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event of joint pain was recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: VICODIN; TRAMADOL; CELEBREX; CYCLOBENZAPRINE

Current Illness:

ID: 1436423
Sex: M
Age:
State: NJ

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Fatigue; Ear pain; This is a spontaneous report received from a contactable consumer, the parent. A 23-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: P6955) in the left arm via an unspecified route on 20Mar2021 at 11:30 as a single dose (at the age of 84-years-old) for COVID-19 immunisation. The patient had no known allergies. Medical history included ADHD. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 12:00, the patient had fatigue and ear pain. The events not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fatigue and ear pain was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436424
Sex: F
Age:
State: OH

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Prolonged fever; body aches and pain; muscle weakness; extreme migraines; nausea; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EN6204) via unspecified route of administration in left arm on date 20Mar2021 (at an age of 24-year-old) at 16:00 for COVID-19 immunisation. Medical history included diabetes since an unknown date also allergic to Red40 and aripiprazole (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6202) via unspecified route of administration on left arm on 27Feb2021 as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and any other medications within 2 weeks of vaccination Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. The patient experienced body aches and pain, extreme migraines, muscle weakness, nausea, prolonged fever on 21Mar2021 at 08:00. It was unknown if the patient received any treatments for the events. The clinical outcome of the events body aches and pain, extreme migraines, muscle weakness, nausea, prolonged fever was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436425
Sex: M
Age:
State: MA

Vax Date: 02/22/2021
Onset Date: 03/01/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Tinnitus; This is a spontaneous report received from a contactable consumer, the patient. A 65 years old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL9265) via an unspecified route in left arm on 22Feb2021, at 09:15 AM as a second single dose for COVID-19 immunisation. The patients medical history included dupuytren's Contracture. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), received in two weeks of vaccination. It was reported that, prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID-19 vaccine and no known allergies to medications, food or other products. On 01Mar2021, the patient experienced developed moderate-severe tinnitus in left ear (patient stated that he had minor tinnitus for many years, but barely noticeable. About 1 week after second dose of vaccine). The patient did not receive any treatment for events. The clinical outcome of tinnitus was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: Vitamin D

Current Illness:

ID: 1436426
Sex: F
Age:
State: IL

Vax Date: 03/14/2021
Onset Date: 03/15/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Intense tightness in neck, shoulders, and both arms.; turn neck right or left, can hear creaking; Muscle spasms in biceps both arms; This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the right arm on 14Mar2021 at 17:30 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included lisinopril 5mg (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. It was unknown that the patient was diagnosed with COVID-19 prior to vaccination. The patient was not tested positive for COVID-19 since having the vaccine. On 15Mar2021 at 08:00, the patient had intense tightness in neck, shoulders and both arms. When patient turn her neck right or left, she can hear creaking and the patient experienced muscle spasms in biceps both arms for a week, range of motion in both arms limited. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of intense tightness in neck, shoulders, and both arms, turn neck right or left, can hear creaking and muscle spasms in biceps both arms was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL

Current Illness:

ID: 1436427
Sex: F
Age:
State: MI

Vax Date: 03/13/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Raised, hot, hard, itchy bump at injection site one week post vaccine.; Weakness; Arthritis in left hand; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 at 09:00 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included psoriasis. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to COVID vaccination. On 20Mar2021 at 23:00, the patient experienced raised, hot, hard, itchy bump at injection site one week post vaccine (vaccination site reactions) and weakness (asthenia) or arthritis in the left hand. The treatment received for the adverse event was unknown. The event resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vaccination site reactions, asthenia and arthritis were not resolved at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1436428
Sex: F
Age:
State: NY

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: metallic taste in mouth; fever; exhaustion; headache; nausea; body ache; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 20Mar2021 at 10:30(at the age of 31 years old) as a single dose for COVID-19 immunisation. Medical history included Multiple chronic illnesses - do not fit in the space allotted. Concomitant medications were reported as Yes, they do not fit in the space provided. Any allergies to medications, food, or other products was reported as Many allergies - I cannot fit them in the space allotted. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 26Feb2021 at 16:45 as a single dose for COVID-19 immunisation. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. since the vaccination, the patient was tested for COVID-19. On 20Mar2021 at 23:30, the patient experienced metallic taste in mouth and otherwise, textbook reaction - fever, exhaustion, headache, nausea, head and body aches. The patient did not receive treatment for the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the metallic taste, fever, exhaustion, headache, nausea, head and body aches was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1436429
Sex: M
Age:
State: OH

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Numbness in the left side of my face as well as both of my lips; Muscle pain all over body; Joint pain all over body; Headache; Elevated temperature of around 99 degrees; Chills; This is a spontaneous report from a contactable consumer. A 39-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) in left arm on 19Mar2021 at 10.45 am as a single dose (at the age of 39 years) for COVID-19 immunisation. Medical history included hypertension and obesity. Concomitant medication included blood pressure medication (not mentioned name of the medication). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 19Mar2021 at 19:45,the patient experienced numbness in the left side of my face as well as both of my lips, muscle pain all over body, joint pain all over body, headache, elevated temperature of around 99 degrees and chills. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not received any treatment for the event. The clinical outcome of the events numbness, muscle pain, joint pain, headache, elevated temperature and chills was still recovering at the time of the reporting. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1436430
Sex: F
Age:
State: CA

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 06/30/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Arm pain; Soreness at injection site; Swollen gland in arm pit; Nausea; Headache; Fatigue; General feeling unwell; This is a spontaneous report received from a contactable consumer, the patient. A 34-Years-Old non-pregnant female patient received second of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: ER2613) via an unspecified route and on right arm on 19Mar2021 ( at 34 years of age )at 09:30 AM as a single dose for COVID-19 immunisation. The patients medical history included allergies to sulfa drugs. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6201) via an unspecified route and on right arm on 26Feb2021, at 09:00 AM as a single dose for COVID-19 immunisation. The patients did not receive any other vaccines within four weeks prior to the COVID vaccine. It was reported that, prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 20Mar2021, at 08:00 AM, the patient experienced soreness at injection site (vaccination site pain), swollen gland in arm pit, incredibly uncomfortable (swollen lymph nodes) nausea, pain in the arm, headache, fatigue and general feeling unwell (feeling unwell). The patient did not receive any treatment for events. The clinical outcome of vaccination site pain, swollen lymph nodes, pain in the arm, nausea, headache, fatigue and feeling unwell was recovering at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm